C82.59 Diffuse follicle center lymphoma, extranodal and solid organ sites

Name of the Condition

• Diffuse Follicle Center Lymphoma, Extranodal and Solid Organ Sites

Summary

Diffuse follicle center lymphoma is a type of non-Hodgkin lymphoma that originates in the lymphatic system, specifically affecting B-cells. It is characterized by the proliferation of cancerous lymphocytes, which can accumulate in lymph nodes and other tissues. When involving extranodal and solid organ sites, the lymphoma affects areas outside the lymph nodes, such as the gastrointestinal tract, skin, or other organs. This condition may present with varying clinical behavior, ranging from indolent to more aggressive forms.

Causes

The exact cause of diffuse follicle center lymphoma is not fully understood, but it is associated with genetic mutations in B-cells. Environmental factors and immune system dysfunction may contribute to its development.

Risk Factors

• Age: More common in individuals over 60.
• Family history: A history of lymphoma can increase risk.
• Immune system deficiencies.
• Certain infections, such as hepatitis C.

Symptoms

• Painless swelling or masses in extranodal sites (e.g., skin, gastrointestinal tract).
• Fatigue.
• Night sweats.
• Unexplained weight loss.
• Fever.

Diagnosis

Diagnosis involves a physical examination, medical history review, blood tests, imaging studies (e.g., CT or PET scans), and a biopsy of affected tissues to confirm the presence and subtype of lymphoma. Additional tests may be performed to evaluate organ involvement.

Treatment Options

• Watchful waiting: Monitoring the condition without immediate treatment if symptoms are mild.
• Radiation therapy: Targeted treatment for localized disease.
• Chemotherapy: Systemic treatment to address widespread or aggressive disease.
• Immunotherapy: Therapies that enhance the immune system's ability to fight cancer.
• Targeted therapy: Drugs designed to target specific cancer cell characteristics.

Prognosis and Follow-Up

Prognosis depends on factors such as the stage of the disease, the patient's overall health, and response to treatment. Regular follow-up appointments, including imaging and blood tests, are typically recommended to monitor for recurrence or progression.

Complications

• Organ dysfunction due to lymphoma infiltration.
• Increased risk of infections.
• Treatment-related side effects (e.g., fatigue, nausea).

Lifestyle & Prevention

• Maintain a healthy lifestyle to support overall immune function.
• Avoid known risk factors, such as smoking or excessive alcohol consumption.
• Stay up-to-date with vaccinations to reduce infection risk.

When to Seek Professional Help

Seek medical attention if you experience persistent symptoms like unexplained weight loss, night sweats, fatigue, or new masses or swelling, especially in extranodal sites.

Tips for Medical Coders

When coding for diffuse follicle center lymphoma involving extranodal and solid organ sites, ensure documentation specifies the affected site(s) to support the use of code C82.59. Verify that the diagnosis aligns with the clinical presentation and that any relevant details (e.g., biopsy results, imaging findings) are clearly documented to confirm the extranodal involvement.